Treatment of rats with Jiangzhi Capsule improves liquid fructose-induced fatty liver: modulation of hepatic expression of SREBP-1c and DGAT-2

BACKGROUND: Jiangzhi Capsule is an Australian listed patented traditional Chinese medicine and has been used for management of lipid abnormalities over the past 10 years. To obtain a better understanding regarding Jiangzhi Capsule, the present study investigated the effects and underlying mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yuanyang, Pan, Yongquan, Yang, Yifan, Batey, Robert, Wang, Jianwei, Li, Yuhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467629/
https://www.ncbi.nlm.nih.gov/pubmed/26031670
http://dx.doi.org/10.1186/s12967-015-0529-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467629/
https://www.ncbi.nlm.nih.gov/pubmed/26031670
http://dx.doi.org/10.1186/s12967-015-0529-6

Ejemplares similares